Showing results (111-120 of 127) with videos related to
Sort By:
Pageof 13
Cytotherapy|November 27, 2022
Allogeneic cord blood regulatory T cells can resolve lung inflammationMi-Ae Lyu, Meixian Huang, Ke Zeng, et al.The International Journal of Biochemistry & Cell Biology|August 30, 2014
Low-dose splenic radiation inhibits liver tumor development of rats through functional changes in CD4+CD25+Treg cellsBaofeng Wang, Baohua Li, Zhijun Dai, et al.Blood|August 25, 2023
Identifying STRN3-RARA as a new fusion gene for acute promyelocytic leukemiaQi Zhang, He Li, Xuelan Chen, et al.Current Pharmaceutical Design|July 30, 2013
Epigenetic interventions increase the radiation sensitivity of cancer cellsJuan Ren, Yongli Chu, Hongbing Ma, et al.Cancer Medicine|April 24, 2026
Mecapegfilgrastim for Prophylaxis of Immunochemotherapy-Induced Neutropenia in Patients With Diffuse Large B-Cell Lymphoma: A Multicenter Pilot TrialJie Wang, He Li, Qiaochu Lin, et al.Current Pharmaceutical Design|July 30, 2013
Relations between GPR4 expression, microvascular density (MVD) and clinical pathological characteristics of patients with epithelial ovarian carcinoma (EOC)Juan Ren, Wen Jin, Yan-E Gao, et al.Investigational New Drugs|January 15, 2022
Bendamustine versus chlorambucil in treatment of chronic lymphocytic leukaemia in China: a randomized, open-label, parallel-controlled, phase III clinical trialDaobin Zhou, Wei Xu, Hongbing Ma, et al.Clinical and Translational Medicine|October 5, 2024
N<sup>6</sup>-methyladenosine-mediated upregulation of LNCAROD confers radioresistance in esophageal squamous cell carcinoma through stabilizing PARP1Xiaobo Shi, Xiaozhi Zhang, Xinran Huang, et al.Current Pharmaceutical Design|July 30, 2013
HDAC as a therapeutic target for treatment of endometrial cancersJuan Ren, Jia Zhang, Hui Cai, et al.International Journal of Clinical and Experimental Medicine|April 23, 2014
RNAi targeting GPR4 influences HMEC-1 gene expression by microarray analysisJuan Ren, Yuelang Zhang, Hui Cai, et al.Pageof 13